| 1 |
王海燕. 慢性肾脏病现状、争议与研究前景[J]. 中华保健医学杂志,2010,12(2):81-82.
|
| 2 |
Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [J]. Lancet, 2012, 379(9818):815-822.
|
| 3 |
Rao M, Pereira BJG. Prospective trials on anemia of chronic disease: The Trial to Reduce Cardiovascular Events with Aranesp?Therapy (TREAT) [J]. Kidney lnt, 2003, 64(Supple 87):S12-S19.
|
| 4 |
林攀, 丁小强, 袁敏,等. 慢性肾脏病患者贫血患者现况调查[J]. 复旦学报(医学版),2009,36(5):562-564.
|
| 5 |
Fishbane S, Pollack S, Feldman HI, et al. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004 [J]. Clin J Am Soc Nephrol, 2009, 4(1):57-61.
|
| 6 |
Bennett L. Patient independence in chronic kidney disease and anaemia: implications of the 2012 kdigo guideline [J]. J Ren Care,2013,39(2):108-117.
|
| 7 |
Uidi GC. Advancements in anemias related to chronic conditions[J]. Clin Chem Lab Med,2010,48(9):1217-1226.
|
| 8 |
Weiss G, Goodnough LT. Anemia of chronic disease [J]. N Engl J Med,2005,352(10):1011-1023.
|
| 9 |
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease[J]. Kidney Int Suppl,2012,2(4):279-335.
|
| 10 |
Foley RN. Treatment of anemia in chronic kidney disease: known,unknown, and both [J]. J Blood Med,2011,2:103-112.
|
| 11 |
Boudville N, Muthucumarana K, Inderjeeth C. Limited referral to nephrologists from a tertiary geriatric outpatient clinic despite a high prevalence of chronic kidney disease and anaemia [J]. BMC Geriatr,2012,12:43.
|
| 12 |
Zhou J, Yuan W, Zhu N, et al. Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and metaanalysis [J]. PLoS One,2012,7(8): e43655.
|
| 13 |
Hörl WH. Clinical aspects of iron use in the anemia of kidney disease [J]. J Am Soc Nephrol,2007,18(2):382-393.
|
| 14 |
KDOQI; National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease,2006[J]. Am J Kidney Dis,2006, 47(5 Suppl 3): S11-145.
|
| 15 |
Macdougall IC, Geisser P. Use of intravenous iron supplementation in chronic kidney disease:an update[J]. Iran J Kidney Dis,2013,7(1):9-22.
|
| 16 |
Coyne DW, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients'Response to IV Iron with Elevated Ferritin (DRIVE) Study [J]. J Am Soc Nephrol,2007,18(3):975-984.
|
| 17 |
范敏华. 静脉铁剂的临床应用[J]. 中国血液净化, 2006, 5(8):407-409.
|
| 18 |
Moore RA, Gaskell H, Rose P, et al. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data[J]. BMC Blood Disord,2011,11:4.
|
| 19 |
Lefebvre P, Duh MS, Mody SH, et al. The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease[J]. Dis Manag,2007,10(1):37-45.
|
| 20 |
Seliger S, Fox KM, Gandra SR, et al. Timing of erythropoiesisstimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study [J]. Clin J Am Soc Nephrol,2010,5(5):882-888.
|
| 21 |
中华医学会肾脏病学分会. 重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J]. 中国血液净化, 2007, 6(8):440-443.
|
| 22 |
Provatopoulou ST, Ziroyiannis PN. Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects [ J].Hippokratia,2011,15(2):109-115.
|
| 23 |
Joshi AD,Holdford DA,Brophy DF,et al. Utilization patterns of IV iron and erythropoiesis stimulating agents in anemic chronic kidney disease patients: a multihospital study [J]. Anemia, 2012, 2012:248430.
|
| 24 |
Fox KM, Yee J, Cong Z, et al. Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study [J].BMC Nephrol,2012,13:5.
|
| 25 |
赵霞. 肾性贫血的基本方[J]. 中国中西医结合肾病杂志,2001,2(11):676.
|
| 26 |
余晓艳, 王亿平. 中西医结合治疗肾性贫血概况[J]. 现代中西医结合杂志,2005,14(20):2755.
|
| 27 |
束永兵, 李传平, 刘贤亮. “加减八珍汤”改善腹膜透析患者营养不良的临床疗效观察[J]. 中国中西医结合肾病杂志, 2011,12(8):724-725.
|
| 28 |
刘春辉. 地黄补血汤配合促红素治疗肾性贫血疗效观察[J]. 山西中医,2012,33(4):407-408.
|
| 29 |
Wu XL, Sun WS, Zhang WG, et al. Clinical study of Trilogy Detoxicating Therapy combined with routine Western medicine on patients with chronic renal failure[J]. Chin J Integr Med,2008,14(2):98-102.
|
| 30 |
檀金川, 胡金焕, 苏敬文. 滋肾生血方对肾性贫血长期血液透析患者内源性促红细胞生成素的影响[J]. 中国中西医结合肾病杂志,2010,30(1):42-44.
|
| 31 |
狄灵, 孙万森, 吴喜利, 等. 绞股蓝总皂甙对肾性贫血大鼠血浆促红细胞生成素含量的影响[J]. 西安交通大学学报(医学版),2003,24(3):273-274.
|
| 32 |
胡江华. 中西医结合治疗肾性贫血临床研究[J]. 实用中医药杂志,2012,28(6):478-479.
|